Clinical trial
Development and Optimization of a GBS Diagnostic Test
NCT00322829 · Laval University, Other · Completed
Key facts
| NCT number | NCT00322829 |
|---|---|
| Title | Development and Optimization of a GBS Diagnostic Test |
| Official title | Development and Optimization of a GBS Micro Total Analysis System (µTAS) Prototype for the Direct Detection of Group B Streptococci in Vaginal/Anal Specimens From Intrapartum Maternity Patients |
| Lead sponsor | Laval University, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Streptococcus Group B |
| Enrollment | 269 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | May 8, 2006 |
| Last update posted | Feb 28, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: